These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29789902)

  • 1. Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris.
    Morishita T; Uzui H; Nakano A; Fukuoka Y; Ikeda H; Amaya N; Kaseno K; Ishida K; Lee JD; Tada H
    Heart Vessels; 2018 Nov; 33(11):1301-1310. PubMed ID: 29789902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
    Kimura S; Sugiyama T; Hishikari K; Nakagama S; Nakamura S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A
    Atherosclerosis; 2020 Jan; 292():127-135. PubMed ID: 31805452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between serum serglycin level and coronary artery disease severity in patients with stable angina pectoris.
    Bolayır HA; Kıvrak T; Gunes H; Bolayır A; Karaca I
    Kardiol Pol; 2018; 76(4):783-790. PubMed ID: 29313562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease.
    Haybar H; Assareh A; Ghotbi Y; Torabizadeh M; Bozorgmanesh M
    Heart; 2013 May; 99(9):640-8. PubMed ID: 23468517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques.
    Matsuura Y; Hatakeyama K; Imamura T; Tsuruda T; Shibata Y; Kodama T; Kitamura K; Asada Y
    J Atheroscler Thromb; 2012; 19(9):837-45. PubMed ID: 22785134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.
    Kanbay M; Ikizek M; Solak Y; Selcoki Y; Uysal S; Armutcu F; Eryonucu B; Covic A; Johnson RJ
    Am J Nephrol; 2011; 33(4):325-31. PubMed ID: 21389698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris.
    Pedersen ER; Tuseth N; Eussen SJ; Ueland PM; Strand E; Svingen GF; Midttun Ø; Meyer K; Mellgren G; Ulvik A; Nordrehaug JE; Nilsen DW; Nygård O
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):455-62. PubMed ID: 25524770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.
    Caselli C; Del Turco S; Ragusa R; Lorenzoni V; De Graaf M; Basta G; Scholte A; De Caterina R; Neglia D
    Cardiovasc Diabetol; 2019 Oct; 18(1):144. PubMed ID: 31672148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in pentraxin-3 level and its interaction with metabolic indices in patients with coronary artery disease and type 2 diabetes mellitus.
    Kravchun PG; Kadykova OI; Molotyagin DG
    Wiad Lek; 2019; 72(2):181-185. PubMed ID: 30903769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.
    Miyazaki T; Chiuve S; Sacks FM; Ridker PM; Libby P; Aikawa M
    PLoS One; 2014; 9(4):e94073. PubMed ID: 24705587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.
    Lee R; Ahn HR; Shin MH; Kim HN; Lee YH; Choi SW; Kweon SS
    J Atheroscler Thromb; 2019 Aug; 26(8):738-745. PubMed ID: 30674758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study.
    Tani S; Nagao K; Yagi T; Atsumi W; Hirayama A
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):49-59. PubMed ID: 27778191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of risk factors in young patients with coronary artery disease in Guangdong and Zhejiang, China.
    Fang C; Chen Y; Nie R; Li G; Xu G; Zhou S; Wang J
    Acta Cardiol; 2009 Apr; 64(2):195-9. PubMed ID: 19476111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.